Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kasper van der Born"'
Autor:
Epie Boven, Kasper van der Born, Godefridus J. Peters, Irene H.L. Hamelers, Caroline A.M. Erkelens, Rutger W.H.M. Staffhorst, Anton I.P.M. de Kroon
Publikováno v:
Staffhorst, R W, van der Born, K, Erkelens, CA, Hamelers, I H, Peters, G J, Boven, E & de Kroon, A I 2008, ' Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts ', Anti-Cancer Drugs, vol. 19, no. 7, pp. 721-727 . https://doi.org/10.1097/CAD.0b013e328304355f
Anti-Cancer Drugs, 19(7), 721-727. Lippincott Williams and Wilkins
Anti-Cancer Drugs, 19(7), 721-727. Lippincott Williams and Wilkins
Cisplatin nanocapsules represent a novel lipid formulation of the anticancer drug cis-diamminedichloridoplatinum(II) (cisplatin), characterized by an unprecedented cisplatin-to-lipid molar ratio, and exhibiting strongly increased in-vitro cytotoxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c797703845190c6b85ccfb9af83fdc
https://doi.org/10.1097/cad.0b013e328304355f
https://doi.org/10.1097/cad.0b013e328304355f
Autor:
Epie Boven, Frederick H. Hausheer, Rita Ruijter, Kasper van der Born, Johannes Berkhof, Miranda Verschraagen, Wim J.F. van der Vijgh
Publikováno v:
Clinical Pharmacology and Therapeutics, 74(2), 157-169. Wiley-Blackwell
Verschraagen, M, Boven, E, Ruijter, R, Van Der Born, K, Berkhof, J, Hausheer, F H & Van Der Vijgh, W J F 2003, ' Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites ', Clinical Pharmacology and Therapeutics, vol. 74, no. 2, pp. 157-169 . https://doi.org/10.1016/S0009-9236(03)00150-4
Verschraagen, M, Boven, E, Ruijter, R, Van Der Born, K, Berkhof, J, Hausheer, F H & Van Der Vijgh, W J F 2003, ' Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites ', Clinical Pharmacology and Therapeutics, vol. 74, no. 2, pp. 157-169 . https://doi.org/10.1016/S0009-9236(03)00150-4
Introduction BNP7787 (disodium 2,2′-dithio-bis-ethane sulfonate) is currently undergoing development as a chemoprotective agent to prevent common and serious cisplatin-induced side effects. In the kidneys, intestine, and liver, BNP7787 is believed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::011a1dd9a3aea543d35f145e79324e79
https://doi.org/10.1016/s0009-9236(03)00150-4
https://doi.org/10.1016/s0009-9236(03)00150-4